Combination therapy • Clinical • Gene therapy • PD(L)-1 Biomarker • IO biomarker • Metastases
|
CD8 (cluster of differentiation 8) • PD-1 (Programmed cell death 1) • IFNG (Interferon, gamma) • IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • CD163 (CD163 Molecule) • NCAM1 (Neural cell adhesion molecule 1) • CCR7 (Chemokine (C-C motif) receptor 7) • CD14 (CD14 Molecule) • CCL2 (Chemokine (C-C motif) ligand 2) • ITGAM (Integrin, alpha M) • CD40 (CD40 Molecule) • CD40LG (CD40 ligand) • IL15 (Interleukin 15) • TAP1 (Transporter 1) • CD80 (CD80 Molecule) • CD86 (CD86 Molecule)
|
nCounter® PanCancer Immune Profiling Panel
|
gemcitabine • delolimogene mupadenorepvec (LOAd703)